| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 17.05.
| Optimer Pharmaceuticals Up 20.5% Since SmarTrend Uptrend Call | | 3 | SmarTrend |
| 15.05.
| Possible Bearish Inside Day Candle Pattern Detected for Optimer Pharmaceuticals | | - | SmarTrend |
| 11.05.
| Loss at Optimer in 1Q | | 1 | Zacks |
| 10.05.
| Optimer Pharmaceuticals Reports First Quarter 2012 Financial Results | | 9 | PR Newswire |
| SAN DIEGO, May 10, 2012 /PRNewswire/ --Optimer Pharmaceuticals, Inc.(NASDAQ: OPTR) today announced the Company's financial results for the quarter ended March 31, 2011.
(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)...
Mehr lesen zu:
Optimer Pharmaceuticals Reports First Quarter 2012 Financial Results | |
| 10.05.
| Optimer Pharmaceuticals Up 21.0% Since SmarTrend Uptrend Call | | - | SmarTrend |
| 08.05.
| Optimer Pharmaceuticals Crosses Below its 10-day MA | | - | SmarTrend |
| 03.05.
| Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | | 25 | PR Newswire |
| SAN DIEGO, May 3, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced that the Company will present at the Bank of America Merrill Lynch2012 Health Care Conference on...
Mehr lesen zu:
Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference | |
| 01.05.
| Optimer Pharmaceuticals Reports Inducement Grants | | 1 | Benzinga.com |
| 01.05.
| Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | | 24 | PR Newswire |
| SAN DIEGO, May 1, 2012 /PRNewswire/ --Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that on April 30, 2012 the Compensation Committee of its Board of Directors approved the grant of...
Mehr lesen zu:
Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | |
| 26.04.
| Uptrend Call Working As Optimer Pharmaceuticals Stock Rises 18.8% | | - | SmarTrend |
| 26.04.
| /C O R R E C T I O N -- Optimer Pharmaceuticals, Inc./ | | 56 | PR Newswire |
| In the news release, Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2012 Financial Results, issued 25-Apr-2012 by Optimer Pharmaceuticals, Inc. over PR Newswire...
Mehr lesen zu:
/C O R R E C T I O N -- Optimer Pharmaceuticals, Inc./ | |
| 25.04.
| Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2012 Financial Results | | 7 | PR Newswire |
| SAN DIEGO, April 25, 2012 /PRNewswire/ --Optimer Pharmaceuticals, Inc.(Nasdaq: OPTR) today announced it will report first quarter 2012 financial results after the NASDAQ Global Marketcloses...
Mehr lesen zu:
Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2012 Financial Results | |
| 11.04.
| Harwood Feffer LLP Announces Investigation of Optimer Pharmaceuticals, Inc. | | 51 | PR Newswire |
| NEW YORK, April 11, 2012 /PRNewswire/ --Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Optimer Pharmaceuticals, Inc. ("Optimer" or the "Company")...
Mehr lesen zu:
Harwood Feffer LLP Announces Investigation of Optimer Pharmaceuticals, Inc. | |
| 11.04.
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Optimer Pharmaceuticals, Inc. | | 12 | PR Newswire |
| NEW YORK, April 11, 2012 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Optimer Pharmaceuticals...
Mehr lesen zu:
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Optimer Pharmaceuticals, Inc. | |
| 10.04.
| Possible Trend Reversal, Optimer Pharmaceuticals Down on Heavy Volume | | - | SmarTrend |
| 09.04.
| Optimer Pharmaceuticals Strips Co-Founder of Chairman Title, Fires Two Execs Over Stock Awards | | 1 | Minyanville |
| 09.04.
| Optimer Pharmaceuticals Crosses Below its 10-day MA | | - | SmarTrend |
| 09.04.
| Optimer Pharmaceuticals Announces Personnel Changes | | 47 | PR Newswire |
| SAN DIEGO, April 9, 2012 /PRNewswire/ --Optimer Pharmaceuticals (NASDAQ: OPTR) ("the Company" or "Optimer") today announced its Board of Directors has appointed Hank McKinnell as its...
Mehr lesen zu:
Optimer Pharmaceuticals Announces Personnel Changes | |
| 02.04.
| Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | | 7 | PR Newswire |
| SAN DIEGO, April 2, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that on March 30, 2012 the Compensation Committee of its Board of Directors approved...
Mehr lesen zu:
Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | |
| 02.04.
| Optimer Pharma (OPTR) Reports Superior Performance from DIFICID Phase 3 vs. Oral Vancomycin | | 1 | StreetInsider.com |
